1. Tijana Spasojević-Došen, Agencija za lijekove i medicinska sredstva Bosne i Hercegovine,
Republic of Srpska, Bosnia and Herzegovina
Presentation of continuous monitoring of antimicrobial drug consumption is very important, since consumption is associated with antimicrobial resistance. Data are collected and processed to be valid, representative and comparable to data on antimicrobial drug consumption in other countries. Valid 2014-2021 total antibacterials for systemic use (J01) data of Bosnia and Herzegovina were analysed according to the WHO Anatomical Therapeutic Chemical (ATC)/Defined Daily Doses (DDD) methodology and expressed in DDD /1000 inhabitants /day (DID). Consumption was also analyzed using the WHO AwaRe (Access, Watch, Reserve) classification. Total antibacterials for systemic use consumption has increased during observatinal period. The top 3 antibacterials (ATC level 5) in 2021 were: amoxicillin and enzyme inhibitor, azithromycin and amoxicillin. Until 2019 Bosnia and Herzegovina had met the WHO target of at least 60% of total consumption being Access agents. During the Covid-19 pandemic, there was an increase in the consumption of antibiotics from the Watch group.
Ključne reči :